Literature DB >> 25975692

[Ultrasonic characteristics of thyroid nodules and diagnostic value of Thyroid Imaging Reporting and Data System (TI-RADS) in the ultrosound evaluation of thyroid nodules].

Xiaoqing Wang1, Xi Wei1, Yong Xu1, Hailing Wang1, Xiaojie Xin1, Sheng Zhang2.   

Abstract

OBJECTIVE: To seek for the ultrasound findings of thyroid nodules related to malignancy and benign, and to assess the role of TI-RADS in the ultrosound evaluation of thyroid nodules.
METHODS: We reviewed and analyzed the ultrasound characteristics of 1838 thyroid nodules confirmed by biopsy or surgical pathology, classified the thyroid nodules by TI-RADS grading criteria, and analyzed the malignancy rate and accuracy rate of different TI-RADS grading.
RESULTS: Among the 1 838 thyroid nodules, 1 160 cases were carcinomas confirmed by surgery, while benign nodules in 212 cases. The sensitivity, specificity, PPV, NPV, and accuracy rates were 99.7% (1 156/1 160), 41.0%(278/678), 74.3% (1 156/1 556), 98.6% (278/282), and 78.2% (1 434/1 838), respectively. There were significant differences between the malignant and benign thyroid nodules in echo, margin, shape, calcification, and blood flow (P<0.001). Hypoechogenicity, marked hypoechogenicity, ill-defined margin, microcalcification, a taller-than-wide shape, and nodule internal rich flow (type III) were significantly associated with malignancy, while hyper/isoechogenicity, smooth margin, macro/no-calcifications, a wider-than-tall shape, and nodules internal poor flow (type I or type II) were significantly associated with benign nodules. There were significant differences between the malignant rates and accuracy rates obtained by different TI-RADS classifications (P<0.01).
CONCLUSION: Understanding the ultrasound characteristics of benign and malignant thyroid nodules and applying TI-RADS grading criteria to correctly classify the thyroid nodules are crucial for the clinical treatment and prognosis.

Entities:  

Mesh:

Year:  2015        PMID: 25975692

Source DB:  PubMed          Journal:  Zhonghua Zhong Liu Za Zhi        ISSN: 0253-3766


  7 in total

1.  Time trend analysis of thyroid cancer surgery in China: single institutional database analysis of 15,000 patients.

Authors:  Chengqiu Sui; Nan Liang; Rui Du; Qiao He; Daqi Zhang; Fang Li; Yantao Fu; Gianlorenzo Dionigi; Hui Sun
Journal:  Endocrine       Date:  2020-03-02       Impact factor: 3.633

2.  Utility of high b-value (2000 sec/mm2) DWI with RESOLVE in differentiating papillary thyroid carcinomas and papillary thyroid microcarcinomas from benign thyroid nodules.

Authors:  Qingjun Wang; Yong Guo; Jing Zhang; Lijing Shi; Haoyong Ning; Xiliang Zhang; Yuanyuan Lu
Journal:  PLoS One       Date:  2018-07-18       Impact factor: 3.240

3.  Diagnostic value of high b-value (2000 s/mm2) DWI for thyroid micronodules.

Authors:  Qingjun Wang; Yong Guo; Jing Zhang; Haoyong Ning; Xiliang Zhang; Yuanyuan Lu; Qinglei Shi
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.817

4.  The application value of modified thyroid imaging report and data system in diagnosing medullary thyroid carcinoma.

Authors:  Jialin Zhu; Xing Li; Xi Wei; Xueling Yang; Jing Zhao; Sheng Zhang; Zhi Guo
Journal:  Cancer Med       Date:  2019-05-09       Impact factor: 4.452

5.  High Risk Thyroid Nodule Discrimination and Management by Modified TI-RADS.

Authors:  Menghui Li; Lijuan Wei; Fangxuan Li; Yanyan Kan; Xiaofeng Liang; Huan Zhang; Juntian Liu
Journal:  Cancer Manag Res       Date:  2021-01-11       Impact factor: 3.989

6.  Ultrasound features of medullary thyroid cancer as predictors of biological behavior.

Authors:  Jingzhu Zhao; Xiangqian Zheng; Ming Gao; Sheng Zhang; Xinwei Yun; Jiadong Chi; Guangwei Xu
Journal:  Cancer Imaging       Date:  2021-04-09       Impact factor: 3.909

7.  The Predictive Value of ACR TI-RADS Classification for Central Lymph Node Metastasis of Papillary Thyroid Carcinoma: A Retrospective Study.

Authors:  Minying Zhong; Zhaoming Zhang; Yisheng Xiao; Yanping He; Yongyu Chen; WeiJun Huang; Liping Lu
Journal:  Int J Endocrinol       Date:  2022-02-07       Impact factor: 3.257

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.